Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00SGZ
|
|||
Former ID |
DIB021243
|
|||
Drug Name |
YM 218
|
|||
Synonyms |
YM-218
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C35H38F2N4O4
|
|||
Canonical SMILES |
CC1=C(C=CO1)C(=O)NC2=CC=C(C=C2)C(=O)N3CCC(C(=CC(=O)N4CCC(CC4)N5CCCCC5)C6=CC=CC=C63)(F)F
|
|||
InChI |
1S/C35H38F2N4O4/c1-24-28(15-22-45-24)33(43)38-26-11-9-25(10-12-26)34(44)41-21-16-35(36,37)30(29-7-3-4-8-31(29)41)23-32(42)40-19-13-27(14-20-40)39-17-5-2-6-18-39/h3-4,7-12,15,22-23,27H,2,5-6,13-14,16-21H2,1H3,(H,38,43)/b30-23-
|
|||
InChIKey |
VDUUABBYYOPFAW-WMMMYUQOSA-N
|
|||
CAS Number |
CAS 425375-94-6
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Vasopressin V1a receptor (V1AR) | Target Info | Antagonist | [2] |
Vasopressin V1b receptor (V1BR) | Target Info | Antagonist | [2] | |
Vasopressin V2 receptor (V2R) | Target Info | Antagonist | [2] | |
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Vascular smooth muscle contraction | ||||
Vasopressin-regulated water reabsorption | ||||
Pathwhiz Pathway | Vasopressin Regulation of Water Homeostasis | |||
Pathway Interaction Database | Arf6 trafficking events | |||
Reactome | Vasopressin-like receptors | |||
G alpha (q) signalling events | ||||
G alpha (s) signalling events | ||||
Vasopressin regulates renal water homeostasis via Aquaporins | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
Regulation of Water Balance by Renal Aquaporins |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2204). | |||
REF 2 | Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors. Pharmacol Res. 2005 Mar;51(3):275-81. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.